MXPA03011153A - Adn enzimas bcl-2. - Google Patents

Adn enzimas bcl-2.

Info

Publication number
MXPA03011153A
MXPA03011153A MXPA03011153A MXPA03011153A MXPA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A MX PA03011153 A MXPA03011153 A MX PA03011153A
Authority
MX
Mexico
Prior art keywords
bcl
dnazymes
catalytic domain
domain
nucleotides
Prior art date
Application number
MXPA03011153A
Other languages
English (en)
Inventor
Sun Lun-Quan
Original Assignee
Johnson & Johnson Res Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Res Pty Ltd filed Critical Johnson & Johnson Res Pty Ltd
Publication of MXPA03011153A publication Critical patent/MXPA03011153A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1135Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/12Type of nucleic acid catalytic nucleic acids, e.g. ribozymes

Abstract

Una prenda desechable incluye una empaquetadura alrededor de una o mas aberturas para las piernas, brazos, cintura o similares sobre un usuario. Por lo menos una parte de la prenda incluye un material elastico de objetivo incluyendo zonas de tension elastica alta y baja y/o de estiramiento alto y bajo en el mismo material integrado durante la formacion del material. El material elastico de objetivo es colocado de manera que por lo menos una zona de alta tension y/o de bajo estiramiento esta alineada con por lo menos una abertura de prenda, y por lo menos una zona de baja tension y/o de alto estiramiento esta alineada hacia adentro de la zona de alta tension y/o de estiramiento, funcionando por tanto como una empaquetadura sin requerir una banda elastica sujetada y fabricada separadamente.
MXPA03011153A 2001-06-07 2002-06-07 Adn enzimas bcl-2. MXPA03011153A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR5527A AUPR552701A0 (en) 2001-06-07 2001-06-07 Bcl-2 dnazymes
PCT/AU2002/000739 WO2002099090A1 (en) 2001-06-07 2002-06-07 Bcl-2 dnazymes

Publications (1)

Publication Number Publication Date
MXPA03011153A true MXPA03011153A (es) 2004-03-26

Family

ID=3829501

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03011153A MXPA03011153A (es) 2001-06-07 2002-06-07 Adn enzimas bcl-2.

Country Status (10)

Country Link
US (1) US20050064407A1 (es)
EP (1) EP1402007A1 (es)
JP (1) JP2004532046A (es)
KR (1) KR20040028771A (es)
AU (1) AUPR552701A0 (es)
BR (1) BR0210189A (es)
CA (1) CA2449940A1 (es)
IL (1) IL159197A0 (es)
MX (1) MXPA03011153A (es)
WO (1) WO2002099090A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482158B2 (en) * 2004-07-01 2009-01-27 Mathison Brian H Composite polynucleic acid therapeutics
CN101940783A (zh) * 2010-08-03 2011-01-12 孙仑泉 脱氧核酶在制备增强肿瘤化疗敏感性的药物中的应用
CN101914538A (zh) * 2010-08-03 2010-12-15 孙仑泉 一种促进肿瘤细胞凋亡的脱氧核酶
CN106047874B (zh) * 2016-06-02 2019-01-18 吉林大学 一种靶向sall4基因的脱氧核酶分子及在乳腺癌基因治疗中的应用
US20210022324A1 (en) * 2018-03-05 2021-01-28 Dr. Reddy's Institute Of Life Sciences Embryonic zebrafish models using dnazyme mediated knockdown
CN112410295B (zh) * 2020-11-20 2023-07-28 华东理工大学 一种控制细胞间相互作用的细胞表面工程方法及其应用
EP4267742A2 (en) 2020-12-28 2023-11-01 1E Therapeutics, Ltd. P21 mrna targeting dnazymes
AU2021411103A1 (en) * 2020-12-28 2023-07-13 1E Therapeutics, Ltd. P21 mrna target areas for silencing
GB202107029D0 (en) * 2021-05-17 2021-06-30 Univ Of Essex Enterprises Limited DNAzyme design

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001992A (en) * 1999-01-07 1999-12-14 Isis Pharmaceuticals Inc. Antisense modulation of novel anti-apoptotic bcl-2-related proteins
US5539094A (en) * 1993-11-12 1996-07-23 La Jolla Cancer Research Foundation DNA encoding Bcl-2-associated proteins
AUPN896596A0 (en) * 1996-03-27 1996-04-26 Walter And Eliza Hall Institute Of Medical Research, The Therapeutic molecules
US6214986B1 (en) * 1998-10-07 2001-04-10 Isis Pharmaceuticals, Inc. Antisense modulation of bcl-x expression

Also Published As

Publication number Publication date
EP1402007A1 (en) 2004-03-31
BR0210189A (pt) 2004-08-03
US20050064407A1 (en) 2005-03-24
CA2449940A1 (en) 2002-12-12
JP2004532046A (ja) 2004-10-21
WO2002099090A1 (en) 2002-12-12
KR20040028771A (ko) 2004-04-03
AUPR552701A0 (en) 2001-07-12
IL159197A0 (en) 2004-06-01

Similar Documents

Publication Publication Date Title
DE69934227D1 (de) Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide
ATE484586T1 (de) Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression
ATE171210T1 (de) Selbststabilisierte oligonukleotide als therapeutika
ATE283923T1 (de) Gene für denitrifizierende enzyme
CA2177732A1 (en) Antisense oligonucleotides having tumorigenicity-inhibiting activity
DK3222722T3 (da) Antisense-design
PL328639A1 (en) Synthesis of p5' phosphoamidane oligonucleotides n3'
MXPA03011153A (es) Adn enzimas bcl-2.
WO2000014217A3 (en) G-motif oligonucleotides and uses thereof
EP3040423A3 (en) Microrna and uses thereof
EP1209228A3 (en) Environmental stress responsive promoter
ATE293688T1 (de) Chimerische antisense-oligonukleotide aus arabinofuranose-analogen und deoxyribose- nukleotide
Kaneko et al. DNA methylation may restrict but does not determine differential gene expression at the Sgy/Tead2 locus during mouse development
ATE317436T1 (de) Genveränderung im gen für die g$g(b)3- untereinheit des humanen g-proteins
US8283462B2 (en) Group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
WO1999028439A3 (fr) Erythrovirus et ses applications
ATE369422T1 (de) Antisense-oligonukleotid zur hemmung der melanom- inhibierenden aktivität (mia)
MX2008013416A (es) Medios para inhibir la expresion de cd31.
AU7425800A (en) Single stranded oligonucleotides, probes, primers and method for detecting spirochetes
IT1320168B1 (it) Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide.
Hosono et al. Properties of base-pairing in the stem region of hairpin antisense oligonucleotides containing 2′-methoxynucleosides
CA2331333A1 (en) Antisense oligonucleotide constructs based on .beta.-arabinofuranose and its analogues
WO2001051670A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
DK1537210T3 (da) Decoy-oligonukleotid-inhibering af CD40-ekspression
HUP0400987A2 (hu) Vírusellenes szerek